Rezidivprophylaxe der Depression: Pharmakologie

Bei der unipolaren Depression zeigt sich eine Rückfallwahrscheinlichkeit von 30–40 % innerhalb des ersten Jahres. Mit jedem Rezidiv steigt das Risiko für eine weitere Episode. Dieser Artikel soll einen Einblick in die Rezidivprophylaxe bei Depression geben, deren primäres Ziel es ist, das Wiederauftreten von neuen depressiven Episoden zu verhindern und einer Chronifizierung der Symptomatik entgegenzuwirken.

• Literatur

• 1 Bauer M, Severus E, Köhler S. et al. W. T. F. o. T. G. f. U. D. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015. World J Biol Psychiatry 2015; 16: 76-95
• 2 Buckman JEJ, Underwood A, Clarke K. et al. Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis. Clin Psychol Rev 2018; 64: 13-38
• 3 DGPPN. S3-Leitlinie/Nationale Versorgungs-Leitlinie Unipolare Depression – Langfassung. 2015 2. Aufl. Im Internet: [Stand: 08.06.2020] https://www.leitlinien.de/mdb/downloads/nvl/depression/depression-2aufl-vers5-lang.pdf
• 4 Busch MA, Maske UE, Ryl L. et al. [Prevalence of depressive symptoms and diagnosed depression among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56: 733-739
• 5 Malhi GS, Mann JJ. Depression. Lancet 2018; 392: 2299-2312
• 6 Alexopoulos GS. Depression in the elderly. The Lancet 2005; 365: 1961-1970
• 7 Stoppel C, Bielau H, Bogerts B. et al. Neurobiological basis of depressive disorders. Fortschr Neurol Psychiatr 2006; 74: 696-705
• 8 Rush AJ, Kraemer HC, Sackeim HA. et al. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacol 2006; 31: 1841-1853
• 9 Cipriani A, Furukawa TA, Salanti G. et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018; 391: 1357-1366
• 10 Bschor T, Bauer M, Adli M. Chronic and treatment resistant depression: diagnosis and stepwise therapy. Dtsch Arztebl Int 2014; 111: 766-775 ; quiz 775
• 11 Adli M, Wiethoff K, Baghai TC. et al. How effective is algorithm-guided treatment for depressed inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 Trial. Int J Neuropsychopharmacol 2017; 20: 721-730
• 12 Ricken R, Wiethoff K, Reinhold T. et al. A standardized stepwise drug treatment algorithm for depression reduces direct treatment costs in depressed inpatients - Results from the German Algorithm Project (GAP3). J Affect Disord 2018; 228: 173-177
• 13 Adli M, Baethge C, Heinz A. et al. Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review. Eur Arch Psychiatry Clin Neurosci 2005; 255: 387-400
• 14 Bschor T, Kern H, Henssler J. et al. Switching the Antidepressant After Nonresponse in Adults With Major Depression: A Systematic Literature Search and Meta-Analysis. J Clin Psychiatry 2018; 79
• 15 Grilo CM, Stout RL, Markowitz JC. et al. Personality disorders predict relapse after remission from an episode of major depressive disorder: a 6-year prospective study. J Clin Psychiatry 2010; 71: 1629-1635
• 16 Clayton AH, Croft HA, Horrigan JP. et al. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry 2006; 67: 736-746
• 17 Henssler J, Bschor T, Baethge C. Combining antidepressants in acute treatment of depression: a meta-analysis of 38 studies including 4511 patients. The Canadian Journal of Psychiatry 2016; 61: 29-43
• 18 Biesheuvel-Leliefeld KE, Kok GD, Bockting CL. et al. Effectiveness of psychological interventions in preventing recurrence of depressive disorder: meta-analysis and meta-regression. J Affect Disord 2015; 174: 400-410
• 19 Voineskos D, Daskalakis ZJ, Blumberger DM. Management of Treatment-Resistant Depression: Challenges and Strategies. Neuropsychiatr Dis Treat 2020; 16: 221-234
• 20 Sackeim HA, Haskett RF, Mulsant BH. et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 2001; 285: 1299-1307
• 21 Brown ED, Lee H, Scott D. et al. Efficacy of continuation/maintenance electroconvulsive therapy for the prevention of recurrence of a major depressive episode in adults with unipolar depression: a systematic review. J ECT 2014; 30: 195-202
• 22 Berlim MT, van den Eynde F, Tovar-Perdomo S. et al. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med 2014; 44: 225-239